BusinessFibrocell Announces FDA Allowance of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized SclerodermaBy Nasdaq OMXMar 6, 2018, 1:02 PM UTC
BusinessMyriad Applauds AACU Position Statement on Molecular Testing for Risk Stratification in Prostate CancerBy Nasdaq OMXMar 6, 2018, 12:05 PM UTC
BusinessAdaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018By Nasdaq OMXMar 5, 2018, 5:12 PM UTC
BusinessPredictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell Society CongressBy Nasdaq OMXMar 5, 2018, 2:15 PM UTC
BusinessAssembly Biosciences to Present at Cowen’s 38th Annual Healthcare ConferenceBy Nasdaq OMXMar 5, 2018, 12:01 PM UTC
BusinessMolecular Templates Closes $10 Million Debt Facility with Perceptive AdvisorsBy Nasdaq OMXMar 2, 2018, 9:30 PM UTC
BusinessRadius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business UpdateBy Nasdaq OMXMar 1, 2018, 9:02 PM UTC
